BofA discloses US consumer watchdog inquiry on Zelle-March 2024-www.financetom.com

Business

BofA discloses US consumer watchdog inquiry on Zelle

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BofA discloses US consumer watchdog inquiry on Zelle

Oct 29, 2024 2:21 PM

Oct 29 (Reuters) - Bank of America ( BAC ) said on

Tuesday it had been responding to an inquiry from the Consumer

Financial Protection Bureau (CFPB) regarding the bank's

processing of funds through Zelle.

Previous page： Revolution Medicines Insider Sold Shares Worth $455,919, According to a Recent SEC Filing Next page： Astera Labs Insider Sold Shares Worth $20,723,773, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Revolution Medicines Insider Sold Shares Worth $455,919, According to a Recent SEC Filing

Mar 20, 2026

04:30 AM EDT, 03/20/2026 (MT Newswires) -- Margaret A Horn, Chief Operating Officer, on March 17, 2026, sold 4,583 shares in Revolution Medicines ( RVMD ) for $455,919. Following the Form 4 filing with the SEC, Horn has control over a total of 157,570 common shares of the company, with 157,570 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000129/xslF345X05/form4.xml ...

Astera Labs Insider Sold Shares Worth $20,723,773, According to a Recent SEC Filing

Mar 20, 2026

04:28 AM EDT, 03/20/2026 (MT Newswires) -- Jitendra Mohan, Director, Chief Executive Officer, on March 17, 2026, sold 157,500 shares in Astera Labs ( ALAB ) for $20,723,773. Following the Form 4 filing with the SEC, Mohan has control over a total of 8,984,472 common shares of the company, with 1,452,739 shares held directly and 7,531,733 controlled indirectly. SEC Filing:...

Revolution Medicines Insider Sold Shares Worth $1,280,412, According to a Recent SEC Filing

Mar 20, 2026

04:29 AM EDT, 03/20/2026 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on March 17, 2026, sold 12,871 shares in Revolution Medicines ( RVMD ) for $1,280,412. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 999,606 common shares of the company, with 276,698 shares held directly and 722,908 controlled...

Revolution Medicines Insider Sold Shares Worth $427,965, According to a Recent SEC Filing

Mar 20, 2026

04:28 AM EDT, 03/20/2026 (MT Newswires) -- Stephen Michael Kelsey, President of Research and Development, on March 17, 2026, sold 4,302 shares in Revolution Medicines ( RVMD ) for $427,965. Following the Form 4 filing with the SEC, Kelsey has control over a total of 295,398 common shares of the company, with 295,398 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000131/xslF345X05/form4.xml ...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP